Biocryst Pharmaceuticals buy Royal Bank of Canada
Start price
30.06.25
/
50%
€7.60
Target price
30.06.26
€11.09
Performance (%)
-0.03%
Price
15:31
€7.60
Summary
This prediction is currently active. The BUY prediction by Royal_Bank_of_Canada for Biocryst Pharmaceuticals is nearly unchanged. This prediction currently runs until 30.06.26. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Biocryst Pharmaceuticals | -0.03% |
| iShares Core DAX® | 2.339% |
| iShares Nasdaq 100 | 2.017% |
| iShares Nikkei 225® | 4.496% |
| iShares S&P 500 | 1.174% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Biocryst Pharmaceuticals diskutieren
BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) had its "outperform" rating re-affirmed by analysts at Royal Bank Of Canada. They now have a $13.00 price target on the stock.
Ratings data for BCRX provided by MarketBeat
Stopped prediction by Royal_Bank_of_Canada for Biocryst Pharmaceuticals
Biocryst Pharmaceuticals
Start price
Target price
Perf. (%)
€8.90
06.05.25
06.05.25
€11.51
06.05.26
06.05.26
-14.59%
15:31
15:31
Biocryst Pharmaceuticals
Start price
Target price
Perf. (%)
€5.91
11.04.25
11.04.25
€9.75
11.04.26
11.04.26
28.60%
15:31
15:31
Biocryst Pharmaceuticals
Start price
Target price
Perf. (%)
€7.79
25.02.25
25.02.25
€10.47
25.02.26
25.02.26
-2.41%
15:31
15:31
Biocryst Pharmaceuticals
Start price
Target price
Perf. (%)
€6.61
05.11.24
05.11.24
€9.16
05.11.25
05.11.25
14.98%
15:31
15:31
Biocryst Pharmaceuticals
Start price
Target price
Perf. (%)
€6.95
25.09.23
25.09.23
€9.44
25.09.24
25.09.24
-2.42%
26.09.24
26.09.24